Specific MiRNA Signatures Are Associated with Metastasis and Poor Prognosis in Clear Cell Renal Cell Carcinoma

Overview

Journal World J Urol

Specialty Urology

Date 2011 Jan 14

PMID 21229250

Citations 108

Authors

Joana Heinzelmann

Brenda Henning

Jimsgene Sanjmyatav

Nicole Posorski

Thomas Steiner

Heiko Wunderlich

Mieczyslaw R Gajda

Kerstin Junker

Affiliations

Soon will be listed here.

Abstract

Purpose: MicroRNAs (miRNAs) play an important role as regulators of gene expression in tumourigenesis by controlling many biological processes in growth, development, differentiation and apoptosis. Previous studies have shown an altered expression of specific miRNAs in clear cell renal cell carcinoma (ccRCC). But the function in cancerogenesis and metastasis in this tumour type is almost unknown. We aimed at identifying specific miRNA expression patterns that are associated with metastasis and prognosis in ccRCC patients.

Methods: MiRNA of 30 human ccRCC including ten non-metastatic tumours, four tumours with metastasis after 3 years or later and four tumours with primary metastasis was isolated. We analysed the miRNA expression by using microarrays and qRT-PCR.

Results: We detected a miRNA signature that distinguishes between metastatic and non-metastatic ccRCC, including miR-451, miR-221, miR-30a, miR-10b and miR-29a. Furthermore, we identified a group of 12 miRNAs, such as let-7 family, miR-30c, miR-26a, which are decreased in highly aggressive primary metastatic tumours. We found also correlations between expression levels of specific miRNAs with progression-free survival and overall survival.

Conclusion: Our findings suggest that specific miRNAs are involved in metastasis and have an impact on the progression of the ccRCC. Furthermore, we identified specific miRNAs characterising very aggressive tumours with early metastasis. In addition, we determined candidate markers associated with survival of the patients. Thus, it seems possible to use miRNAs for prediction of progression to distant metastasis and prognosis analysing the primary tumour.

Citing Articles

The Prognostic Role of miR-375 in Head and Neck Squamous Cell Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

Dioguardi M, Musella G, Bizzoca M, Sovereto D, Guerra C, Laterza P Int J Mol Sci. 2025; 26(5).

PMID: 40076805 PMC: 11900050. DOI: 10.3390/ijms26052183.

Characterization and analysis of extracellular vesicle-derived miRNAs from different adipose tissues in mice.

Wang J, Ji Y, Cao X, Shi R, Lu X, Wang Y Heliyon. 2024; 10(20):e39149.

PMID: 39640764 PMC: 11620040. DOI: 10.1016/j.heliyon.2024.e39149.

Effect of endometriosis on prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.

He Y, Cao B, Huang Y Front Oncol. 2024; 14:1438309.

PMID: 39619433 PMC: 11604584. DOI: 10.3389/fonc.2024.1438309.

Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer.

Yu X, Du Z, Zhu P, Liao B Pharmacol Rep. 2024; 76(2):273-286.

PMID: 38388810 DOI: 10.1007/s43440-024-00568-7.

MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.

Caetano S, Garcia A, Figueira I, Brito M Int J Mol Sci. 2023; 24(18).

PMID: 37762600 PMC: 10531597. DOI: 10.3390/ijms241814297.

References

Scott G, Goga A, Bhaumik D, Berger C, Sullivan C, Benz C . Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem. 2006; 282(2):1479-86. DOI: 10.1074/jbc.M609383200. View

Nicoloso M, Spizzo R, Shimizu M, Rossi S, Calin G . MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009; 9(4):293-302. DOI: 10.1038/nrc2619. View

Ramaswamy S, Ross K, Lander E, Golub T . A molecular signature of metastasis in primary solid tumors. Nat Genet. 2002; 33(1):49-54. DOI: 10.1038/ng1060. View

Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H . Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64(11):3753-6. DOI: 10.1158/0008-5472.CAN-04-0637. View

Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T . Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol. 2008; 216(4):418-27. DOI: 10.1002/path.2437. View

Croce C, Calin G . miRNAs, cancer, and stem cell division. Cell. 2005; 122(1):6-7. DOI: 10.1016/j.cell.2005.06.036. View

Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E . MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007; 104(40):15805-10. PMC: 2000384. DOI: 10.1073/pnas.0707628104. View

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P . Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18(3):581-92. DOI: 10.1093/annonc/mdl498. View

Calin G, Croce C . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. DOI: 10.1038/nrc1997. View

10.

Yi Z, Fu Y, Zhao S, Zhang X, Ma C . Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol. 2009; 136(6):855-62. DOI: 10.1007/s00432-009-0726-x. View

11.

Chow T, Youssef Y, Lianidou E, Romaschin A, Honey R, Stewart R . Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin Biochem. 2009; 43(1-2):150-8. DOI: 10.1016/j.clinbiochem.2009.07.020. View

12.

Baffa R, Fassan M, Volinia S, OHara B, Liu C, Palazzo J . MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009; 219(2):214-21. DOI: 10.1002/path.2586. View

13.

Thoenes W, Storkel S, Rumpelt H . Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract. 1986; 181(2):125-43. DOI: 10.1016/S0344-0338(86)80001-2. View

14.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P . Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 2010; 29:90. PMC: 2907341. DOI: 10.1186/1756-9966-29-90. View

15.

Sengupta S, den Boon J, Chen I, Newton M, Stanhope S, Cheng Y . MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008; 105(15):5874-8. PMC: 2311339. DOI: 10.1073/pnas.0801130105. View

16.

Storkel S, van den Berg E . Morphological classification of renal cancer. World J Urol. 1995; 13(3):153-8. DOI: 10.1007/BF00184870. View

17.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

18.

Juan D, Alexe G, Antes T, Liu H, Madabhushi A, DeLisi C . Identification of a microRNA panel for clear-cell kidney cancer. Urology. 2009; 75(4):835-41. DOI: 10.1016/j.urology.2009.10.033. View

19.

Dangi-Garimella S, Yun J, Eves E, Newman M, Erkeland S, Hammond S . Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009; 28(4):347-58. PMC: 2646152. DOI: 10.1038/emboj.2008.294. View

20.

Ljungberg B . Prognostic factors in renal cell carcinoma. Urologe A. 2004; 43 Suppl 3:S119-20. DOI: 10.1007/s00120-004-0594-6. View